AU2183177A - Polypeptide derivatives - Google Patents

Polypeptide derivatives

Info

Publication number
AU2183177A
AU2183177A AU21831/77A AU2183177A AU2183177A AU 2183177 A AU2183177 A AU 2183177A AU 21831/77 A AU21831/77 A AU 21831/77A AU 2183177 A AU2183177 A AU 2183177A AU 2183177 A AU2183177 A AU 2183177A
Authority
AU
Australia
Prior art keywords
polypeptide derivatives
polypeptide
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU21831/77A
Other versions
AU514965B2 (en
Inventor
W. Cardinaux F. Dr. Huguenin R. Dr. Pless J. and Sandrin E Bauer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of AU2183177A publication Critical patent/AU2183177A/en
Application granted granted Critical
Publication of AU514965B2 publication Critical patent/AU514965B2/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B63—SHIPS OR OTHER WATERBORNE VESSELS; RELATED EQUIPMENT
    • B63B—SHIPS OR OTHER WATERBORNE VESSELS; EQUIPMENT FOR SHIPPING 
    • B63B1/00—Hydrodynamic or hydrostatic features of hulls or of hydrofoils
    • B63B1/02—Hydrodynamic or hydrostatic features of hulls or of hydrofoils deriving lift mainly from water displacement
    • B63B1/10—Hydrodynamic or hydrostatic features of hulls or of hydrofoils deriving lift mainly from water displacement with multiple hulls
    • B63B1/107—Semi-submersibles; Small waterline area multiple hull vessels and the like, e.g. SWATH
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B63—SHIPS OR OTHER WATERBORNE VESSELS; RELATED EQUIPMENT
    • B63B—SHIPS OR OTHER WATERBORNE VESSELS; EQUIPMENT FOR SHIPPING 
    • B63B35/00—Vessels or similar floating structures specially adapted for specific purposes and not otherwise provided for
    • B63B35/44—Floating buildings, stores, drilling platforms, or workshops, e.g. carrying water-oil separating devices
    • B63B35/4413—Floating drilling platforms, e.g. carrying water-oil separating devices
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/70—Enkephalins
    • C07K14/702—Enkephalins with at least 1 amino acid in D-form
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Combustion & Propulsion (AREA)
  • Veterinary Medicine (AREA)
  • Ocean & Marine Engineering (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mechanical Engineering (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Architecture (AREA)
  • Toxicology (AREA)
  • Civil Engineering (AREA)
  • Structural Engineering (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Fluid Mechanics (AREA)
  • Psychiatry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU21831/77A 1976-02-02 1977-02-01 Polypeptide derivatives Expired AU514965B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH126676A CH619686A5 (en) 1976-02-02 1976-02-02 Process for the preparation of novel peptides or peptide derivatives
CHCH1266/76 1976-02-02

Publications (2)

Publication Number Publication Date
AU2183177A true AU2183177A (en) 1978-08-10
AU514965B2 AU514965B2 (en) 1981-03-12

Family

ID=4206368

Family Applications (1)

Application Number Title Priority Date Filing Date
AU21831/77A Expired AU514965B2 (en) 1976-02-02 1977-02-01 Polypeptide derivatives

Country Status (3)

Country Link
AU (1) AU514965B2 (en)
CH (1) CH619686A5 (en)
ZA (1) ZA77579B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4251439A (en) * 1979-12-17 1981-02-17 Eli Lilly And Company Pharmacologically active peptides
US4283329A (en) * 1979-12-17 1981-08-11 Eli Lilly And Company Pharmacologically active peptides
US4322339A (en) * 1980-10-20 1982-03-30 Eli Lilly And Company Pharmacologically active peptides
US4322340A (en) * 1980-10-20 1982-03-30 Eli Lilly And Company Pharmacologically active peptides

Also Published As

Publication number Publication date
AU514965B2 (en) 1981-03-12
ZA77579B (en) 1978-09-27
CH619686A5 (en) 1980-10-15

Similar Documents

Publication Publication Date Title
AU508025B2 (en) Polypeptide
AU2902577A (en) 4-n-acylfortimicin b derivatives
AU509754B2 (en) Benazepine derivatives
AU517585B2 (en) Phenoxybenzyloxycarbonyl derivatives
AU510760B2 (en) Peptide derivatives
AU507258B2 (en) Fluoroacacylresorcin derivatives
AU504526B2 (en) Pipeazine derivatives
AU503893B2 (en) Polypeptide
AU517829B2 (en) Morphanthridine derivatives
AU502122B2 (en) 5-0-acylated-imidazole-4-carboxamide derivatives
AU515192B2 (en) Quinoxaline-din-oxide derivatives
AU514965B2 (en) Polypeptide derivatives
AU512647B2 (en) Solpenamide derivatives
AU511452B2 (en) Peptide derivatives
AU507708B2 (en) Hydrazino-pyridazine derivatives
AU514803B2 (en) 4-phenylpipridine derivatives
AU513069B2 (en) 17-spirosiltine derivatives
AU505150B2 (en) Triazolobenzazepine derivatives
AU511948B2 (en) Nortropine-carbazate derivatives
AU519085B2 (en) 1-carba-2-penem derivatives
AU503490B2 (en) Aminoalkyl-dibenzocyclohepton-5-one derivatives
AU1858676A (en) Aminoalkyl-dibenzocyclohepton-5-one derivatives
AU508555B2 (en) 6-carboxy-flavone derivatives
AU540464B2 (en) Morphanthridine derivatives
AU512688B2 (en) Thienyl-and T-aminophenyl-pyrrolidine derivatives